Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06367972 · ClinicalTrials.gov registry record · Phase 2
A Randomized Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP)
A Phase 2 study of OligoProgressive Metastatic Disease, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT06367972 is a Phase 2 study of OligoProgressive Metastatic Disease that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 400 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06367972, a Phase 2 study of OligoProgressive Metastatic Disease, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
To find out if local consolidation therapy (such as radiation therapy with or without other local therapies such as surgery, ablation \[the removal or destruction of a body part or tissue or its function\], or embolization \[a procedure that uses particles, such as tiny gelatin sponges or beads, to block a blood vessel\]) to all progressive sites of disease can help to control the disease compared with next-line systemic therapy.
Conditions Studied
Interventions
- PROCEDURE Local Consolidation Therapy
- PROCEDURE Next-line Systemic Therapy
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2024-06-06 |
| Est. Completion | 2030-10-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06367972
The ClinicalTrials.gov registry entry for NCT06367972 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with OligoProgressive Metastatic Disease appearing as the primary indexed condition, and to 2 interventions - of which Local Consolidation Therapy is the first listed.
NCT06367972 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06367972 about?
NCT06367972 is a clinical study titled "A Randomized Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP)". To find out if local consolidation therapy (such as radiation therapy with or without other local therapies such as surgery, ablation \[the removal or destruction of a body part or tissue or its function\], or embolization \[a procedure that uses particles, such as tiny gelatin sponges or beads, to ...
What is the current status of trial NCT06367972?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 400 participants. The study started on 2024-06-06. Estimated completion is 2030-10-10.
What conditions does trial NCT06367972 study?
This clinical trial studies the following conditions: OligoProgressive Metastatic Disease.
What interventions are being tested in trial NCT06367972?
The interventions under investigation include: Local Consolidation Therapy (PROCEDURE), Next-line Systemic Therapy (PROCEDURE).
Who is sponsoring clinical trial NCT06367972?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06367972 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for OligoProgressive Metastatic Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.